The Next Generation Sequencing Services Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Type (Human Genome Sequencing, Single Cell Sequencing, Microbial Genome-based Sequencing, Gene Regulation Services, Small RNA Sequencing, ChIP Sequencing, Others, Animal & Plant Sequencing, Others), By Workflow (Pre-sequencing, Sequencing, Data Analysis), By End-User (Research Institutes, Hospitals & Clinics, Pharma & Biotech Entities, Others).
Next Generation Sequencing Services offer comprehensive solutions for researchers and healthcare providers seeking to leverage the power of high-throughput sequencing technologies without the need for extensive infrastructure and expertise. These service providers offer a range of sequencing applications, including whole genome sequencing, exome sequencing, transcriptome analysis, and targeted sequencing, tailored to specific research or clinical objectives. By outsourcing sequencing workflows to specialized facilities, researchers and clinicians can access state-of-the-art instrumentation, bioinformatics support, and quality assurance protocols, streamlining the sequencing process and accelerating scientific discoveries or diagnostic insights. With a focus on scalability, reliability, and data security, Next Generation Sequencing Services are driving innovation and accessibility in genomic research and precision medicine initiatives worldwide.
A significant trend in the next-generation sequencing (NGS) services market is the increasing demand for customized and specialized NGS services. As genomic research and clinical applications continue to evolve, there is a growing need for NGS service providers that can offer tailored solutions to meet diverse research and diagnostic requirements. This trend reflects a shift towards personalized medicine approaches and precision genomic analysis, driving the demand for NGS services that provide specialized assays, customized workflows, and expert bioinformatics support. NGS service providers are expanding their offerings to include niche services such as single-cell sequencing, epigenomics, metagenomics, and RNA sequencing, catering to the unique needs of academic researchers, biotechnology companies, and clinical laboratories seeking comprehensive genomic solutions.
A key driver for the next-generation sequencing (NGS) services market is the continuous advancements in NGS technologies and bioinformatics capabilities. The rapid pace of innovation in NGS platforms, sequencing chemistries, and data analysis tools has enabled higher throughput, improved accuracy, and reduced costs for genomic sequencing and analysis. Additionally, advancements in bioinformatics algorithms, cloud computing, and data management systems have enhanced the scalability, speed, and accuracy of NGS data analysis, enabling researchers and clinicians to extract meaningful insights from large-scale genomic datasets. This driver fuels the adoption of NGS services by providing access to state-of-the-art technologies and expertise for genomic research, clinical diagnostics, and drug discovery applications.
An emerging opportunity within the next-generation sequencing (NGS) services market lies in the expansion into clinical genomics and diagnostic testing services. With the increasing adoption of NGS-based tests in clinical practice for diagnosing genetic disorders, predicting disease risk, and guiding treatment decisions, there is a growing demand for accredited NGS service providers that can deliver reliable and clinically validated genomic testing services. NGS service providers have the opportunity to collaborate with healthcare institutions, diagnostic laboratories, and pharmaceutical companies to develop and offer comprehensive NGS-based diagnostic panels for a wide range of genetic conditions. By leveraging their expertise in genomic sequencing, data analysis, and quality assurance, NGS service providers can address unmet needs in clinical genomics testing and contribute to advancements in personalized medicine and precision diagnostics. This presents an opportunity for NGS service providers to expand their service offerings into the clinical market, driving revenue growth and market differentiation in the rapidly evolving landscape of genomic medicine.
The fastest-growing segment in the Next Generation Sequencing (NGS) Services Market is Single Cell Sequencing services within Human Genome Sequencing. This growth is propelled by the increasing demand for high-resolution analysis of individual cells, enabling researchers to study cellular heterogeneity and uncover insights into complex biological processes at the single-cell level. Single Cell Sequencing services offer unparalleled insights into gene expression, cellular interactions, and disease mechanisms, driving innovation in areas such as cancer research, immunology, and developmental biology. Additionally, the expanding applications of Single Cell Sequencing across research institutes, hospitals, pharmaceutical, and biotech entities contribute significantly to its rapid growth within the NGS Services Market.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossApplied Biological Materials Inc, ARUP Laboratories, Azenta Life Sciences, BGI Group, Gene By Gene Ltd, Illumina Inc, Lucigen Corp, NanoString Technologies Inc, Novogene Co. Ltd, Pacific Biosciences of California Inc, Quest Diagnostics Inc, Veritas Genetics
By Type
Human Genome Sequencing
Single Cell Sequencing
Microbial Genome-based Sequencing
Gene Regulation Services
Small RNA Sequencing
ChIP Sequencing
Others
Animal & Plant Sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By End-User
Research Institutes
Hospitals & Clinics
Pharma & Biotech Entities
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Applied Biological Materials Inc
ARUP Laboratories
Azenta Life Sciences
BGI Group
Gene By Gene Ltd
Illumina Inc
Lucigen Corp
NanoString Technologies Inc
Novogene Co. Ltd
Pacific Biosciences of California Inc
Quest Diagnostics Inc
Veritas Genetics
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Next Generation Sequencing Services Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Next Generation Sequencing Services Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Next Generation Sequencing Services Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Next Generation Sequencing Services Market Size Outlook, $ Million, 2021 to 2030
3.2 Next Generation Sequencing Services Market Outlook by Type, $ Million, 2021 to 2030
3.3 Next Generation Sequencing Services Market Outlook by Product, $ Million, 2021 to 2030
3.4 Next Generation Sequencing Services Market Outlook by Application, $ Million, 2021 to 2030
3.5 Next Generation Sequencing Services Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Next Generation Sequencing Services Industry
4.2 Key Market Trends in Next Generation Sequencing Services Industry
4.3 Potential Opportunities in Next Generation Sequencing Services Industry
4.4 Key Challenges in Next Generation Sequencing Services Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Next Generation Sequencing Services Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Next Generation Sequencing Services Market Outlook by Segments
7.1 Next Generation Sequencing Services Market Outlook by Segments, $ Million, 2021- 2030
By Type
Human Genome Sequencing
Single Cell Sequencing
Microbial Genome-based Sequencing
Gene Regulation Services
Small RNA Sequencing
ChIP Sequencing
Others
Animal & Plant Sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By End-User
Research Institutes
Hospitals & Clinics
Pharma & Biotech Entities
Others
8 North America Next Generation Sequencing Services Market Analysis and Outlook To 2030
8.1 Introduction to North America Next Generation Sequencing Services Markets in 2024
8.2 North America Next Generation Sequencing Services Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Next Generation Sequencing Services Market size Outlook by Segments, 2021-2030
By Type
Human Genome Sequencing
Single Cell Sequencing
Microbial Genome-based Sequencing
Gene Regulation Services
Small RNA Sequencing
ChIP Sequencing
Others
Animal & Plant Sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By End-User
Research Institutes
Hospitals & Clinics
Pharma & Biotech Entities
Others
9 Europe Next Generation Sequencing Services Market Analysis and Outlook To 2030
9.1 Introduction to Europe Next Generation Sequencing Services Markets in 2024
9.2 Europe Next Generation Sequencing Services Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Next Generation Sequencing Services Market Size Outlook by Segments, 2021-2030
By Type
Human Genome Sequencing
Single Cell Sequencing
Microbial Genome-based Sequencing
Gene Regulation Services
Small RNA Sequencing
ChIP Sequencing
Others
Animal & Plant Sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By End-User
Research Institutes
Hospitals & Clinics
Pharma & Biotech Entities
Others
10 Asia Pacific Next Generation Sequencing Services Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Next Generation Sequencing Services Markets in 2024
10.2 Asia Pacific Next Generation Sequencing Services Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Next Generation Sequencing Services Market size Outlook by Segments, 2021-2030
By Type
Human Genome Sequencing
Single Cell Sequencing
Microbial Genome-based Sequencing
Gene Regulation Services
Small RNA Sequencing
ChIP Sequencing
Others
Animal & Plant Sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By End-User
Research Institutes
Hospitals & Clinics
Pharma & Biotech Entities
Others
11 South America Next Generation Sequencing Services Market Analysis and Outlook To 2030
11.1 Introduction to South America Next Generation Sequencing Services Markets in 2024
11.2 South America Next Generation Sequencing Services Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Next Generation Sequencing Services Market size Outlook by Segments, 2021-2030
By Type
Human Genome Sequencing
Single Cell Sequencing
Microbial Genome-based Sequencing
Gene Regulation Services
Small RNA Sequencing
ChIP Sequencing
Others
Animal & Plant Sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By End-User
Research Institutes
Hospitals & Clinics
Pharma & Biotech Entities
Others
12 Middle East and Africa Next Generation Sequencing Services Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Next Generation Sequencing Services Markets in 2024
12.2 Middle East and Africa Next Generation Sequencing Services Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Next Generation Sequencing Services Market size Outlook by Segments, 2021-2030
By Type
Human Genome Sequencing
Single Cell Sequencing
Microbial Genome-based Sequencing
Gene Regulation Services
Small RNA Sequencing
ChIP Sequencing
Others
Animal & Plant Sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By End-User
Research Institutes
Hospitals & Clinics
Pharma & Biotech Entities
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Applied Biological Materials Inc
ARUP Laboratories
Azenta Life Sciences
BGI Group
Gene By Gene Ltd
Illumina Inc
Lucigen Corp
NanoString Technologies Inc
Novogene Co. Ltd
Pacific Biosciences of California Inc
Quest Diagnostics Inc
Veritas Genetics
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
Human Genome Sequencing
Single Cell Sequencing
Microbial Genome-based Sequencing
Gene Regulation Services
Small RNA Sequencing
ChIP Sequencing
Others
Animal & Plant Sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By End-User
Research Institutes
Hospitals & Clinics
Pharma & Biotech Entities
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Next Generation Sequencing Services Market is one of the lucrative growth markets, poised to register a 21.6% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Applied Biological Materials Inc, ARUP Laboratories, Azenta Life Sciences, BGI Group, Gene By Gene Ltd, Illumina Inc, Lucigen Corp, NanoString Technologies Inc, Novogene Co. Ltd, Pacific Biosciences of California Inc, Quest Diagnostics Inc, Veritas Genetics
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume